BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33363048)

  • 1. The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients-A Pilot Study.
    Shi W; Shen L; Zou W; Wang J; Yang J; Wang Y; Liu B; Xie L; Zhu J; Zhang Z
    Front Cell Infect Microbiol; 2020; 10():562463. PubMed ID: 33363048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study.
    Yi Y; Shen L; Shi W; Xia F; Zhang H; Wang Y; Zhang J; Wang Y; Sun X; Zhang Z; Zou W; Yang W; Zhang L; Zhu J; Goel A; Ma Y; Zhang Z
    Clin Cancer Res; 2021 Mar; 27(5):1329-1340. PubMed ID: 33298472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer.
    Wang H; Jia H; Gao Y; Zhang H; Fan J; Zhang L; Ren F; Yin Y; Cai Y; Zhu J; Zhu ZJ
    Nat Commun; 2022 Dec; 13(1):7802. PubMed ID: 36528604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metagenomic Analysis of Intratumoral Microbiome Linking to Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.
    Huang X; Chen C; Xie W; Zhou C; Tian X; Zhang Z; Wang Q; Chang H; Xiao W; Zhang R; Gao Y
    Int J Radiat Oncol Biol Phys; 2023 Dec; 117(5):1255-1269. PubMed ID: 37433373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota-mediated nucleotide synthesis attenuates the response to neoadjuvant chemoradiotherapy in rectal cancer.
    Teng H; Wang Y; Sui X; Fan J; Li S; Lei X; Shi C; Sun W; Song M; Wang H; Dong D; Geng J; Zhang Y; Zhu X; Cai Y; Li Y; Li B; Min Q; Wang W; Zhan Q
    Cancer Cell; 2023 Jan; 41(1):124-138.e6. PubMed ID: 36563680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Predictive Markers for Response to Neoadjuvant Chemoradiation in Rectal Carcinomas by Proteomic Isotope Coded Protein Label (ICPL) Analysis.
    Croner RS; Sevim M; Metodiev MV; Jo P; Ghadimi M; Schellerer V; Brunner M; Geppert C; Rau T; Stürzl M; Naschberger E; Matzel KE; Hohenberger W; Lottspeich F; Kellermann J
    Int J Mol Sci; 2016 Feb; 17(2):209. PubMed ID: 26861291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective, longitudinal analysis of the gut microbiome in patients with locally advanced rectal cancer predicts response to neoadjuvant concurrent chemoradiotherapy.
    Sun Y; Zhang X; Jin C; Yue K; Sheng D; Zhang T; Dou X; Liu J; Jing H; Zhang L; Yue J
    J Transl Med; 2023 Mar; 21(1):221. PubMed ID: 36967379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot proteomic study of locally advanced rectal cancer before and after neoadjuvant chemoradiotherapy indicates high metabolic activity in non-responders' tumor tissue.
    Babic T; Lygirou V; Rosic J; Miladinov M; Rom AD; Baira E; Stroggilos R; Pappa E; Zoidakis J; Krivokapic Z; Nikolic A
    Proteomics Clin Appl; 2023 Jan; 17(1):e2100116. PubMed ID: 35997210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of protein clusters predictive of tumor response in rectal cancer patients receiving neoadjuvant chemo-radiotherapy.
    Repetto O; De Re V; De Paoli A; Belluco C; Alessandrini L; Canzonieri V; Cannizzaro R
    Oncotarget; 2017 Apr; 8(17):28328-28341. PubMed ID: 28423701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
    Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
    BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-Occurrence of Symptoms and Gut Microbiota Composition Before Neoadjuvant Chemotherapy and Radiation Therapy for Rectal Cancer: A Proof of Concept.
    González-Mercado VJ; Lim J; Yu G; Penedo F; Pedro E; Bernabe R; Tirado-Gómez M; Aouizerat B
    Biol Res Nurs; 2021 Jul; 23(3):513-523. PubMed ID: 33541122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Identification of gene biomarkers to predict responses to neoadjuvant chemoradiotherapy in patients with rectal cancer and pathways enrichment analysis].
    Wang XJ; Yu Q; Chi P; Lin HM; Lu XR; Huang Y; Xu ZB; Huang SH; Sun YW; Ye DX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1183-1187. PubMed ID: 31874536
    [No Abstract]   [Full Text] [Related]  

  • 13. Gut microbiota differences in Island Hispanic Puerto Ricans and mainland non-Hispanic whites during chemoradiation for rectal cancer: A pilot study.
    González-Mercado VJ; Lim J; Berk L; Esele M; Rodríguez CS; Colón-Otero G
    Curr Probl Cancer; 2020 Aug; 44(4):100551. PubMed ID: 32057462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Poor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer Using a DNA Repair Deregulation Score: Picking the Losers Instead of the Winners.
    Jimenez L; Perez RO; São Julião GP; Vailati BB; Fernandez LM; Gama-Rodrigues J; Habr-Gama A; DeVecchio J; Kalady MF; Camargo AA
    Dis Colon Rectum; 2020 Mar; 63(3):300-309. PubMed ID: 31842156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Changes in Penile Microbiome Following Pediatric Circumcision.
    Mishra K; Isali I; Sindhani M; Prunty M; Bell S; Mahran A; Damiani G; Ghannoum M; Retuerto M; Kutikov A; Ross J; Woo LL; Abbosh PH; Bukavina L
    Eur Urol Focus; 2023 Jul; 9(4):669-680. PubMed ID: 36566099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
    Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
    [No Abstract]   [Full Text] [Related]  

  • 17. Rectal Cancer Tissue Lipidome Differs According to Response to Neoadjuvant Therapy.
    Sánchez-Vinces S; Duarte GHB; Messias MCF; Gatinoni CFA; Silva AAR; Sanches PHG; Martinez CAR; Porcari AM; Carvalho PO
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of tumor response after neoadjuvant chemoradiotherapy in rectal cancer using (18)fluorine-2-deoxy-D-glucose positron emission tomography-computed tomography and serum carcinoembryonic antigen: a prospective study.
    Li QW; Zheng RL; Ling YH; Wang QX; Xiao WW; Zeng ZF; Fan W; Li LR; Gao YH
    Abdom Radiol (NY); 2016 Aug; 41(8):1448-55. PubMed ID: 27116012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["Watch and wait" strategy after neoadjuvant therapy for rectal cancer: status survey of perceptions, attitudes and treatment selection in Chinese surgeons].
    Sun TT; Wang L; Yao YF; Peng YF; Zhao J; Zhan TC; Leng JH; Wang HY; Chen N; Chen PJ; Li YJ; Zhang X; Liu XZ; Zhang Y; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):550-559. PubMed ID: 31238634
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.